Pfizer

It is a potentially game-changing development, especially when it comes to schools getting back to normal during this pandemic.

Pfizer said Monday early trial results indicate its COVID-19 vaccine is safe and effective for children ages 5 to 11

Pfizer says its COVID-19 vaccine works for children ages 5 to 11

A panel of outside experts who advise the Food and Drug Administration voted not to endorse COVID-19 booster shots of the Pfizer vaccine.

An influential federal advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe disease.

FDA advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective — the first step toward deciding which Americans need one and when.

Pharmaceutical giant BioNTech, which worked with Pfizer to create their mRNA coronavirus vaccine, told German news weekly Der Spiegel in an interview published Friday that it would be seeking FDA approval “over the next few weeks” for use of its vaccine in children ages 5 to 11.

COVID-19 booster shots may be coming for at least some Americans but there’s still important science to be worked out about who really needs them and when. Here’s what we know about the biology behind booster decisions

Now that the Pfizer vaccine has attained full FDA approval, there may be more vaccine requirements in the workplace. NBC 6’s Carlos Suarez reports.

The FDA gave Pfizer-BioNTech’s two-dose coronavirus vaccine full approval on Monday for all Americans over the age of 16. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to receive full approval by the agency. NBC 6’s Trina Robinson reports.

Now that the FDA has given the Pfizer-BioNTech COVID-19 vaccine its stamp of full approval, doctors hope that some vaccine skeptics will finally be convinced to get the shot. As NBC News medical contributor Dr. Kavita Patel explains, the approval is also likely to lead to more vaccine mandates by employers.

The U.S. has given full approval to the COVID-19 vaccine made by Pfizer

U.S. health officials are expected to announce that they recommend booster shots of the COVID-19 vaccine eight months after receiving the second dose, according to sources.

U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot.

Facebook has removed hundreds of accounts linked to a disinformation network operating out of Russia that sought to smear COVID-19 vaccines made by Pfizer and AstraZeneca.

A preliminary survey out of Israel suggests that a coronavirus booster shot may cause similar side effects to the second dose.

“I was generally encouraged by the results of the paper,” the study’s lead author said.

During an earnings call this morning, Pfizer announced a third dose of its COVID-19 vaccine boosts protection against the Delta variant.

White House press secretary Jen Psaki confirmed the U.S. has agreed to purchase 200 million additional doses of the Pfizer/BioNtech COVID-19 vaccine.